Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer

Journal of Surgical Oncology

Volumn 103, Issue 7, 2011, Pages 695-699

  Yasuda, Hiromi ^a   Toiyama, Yuji ^a   Ohi, Masaki ^a   Mohri, Yasuhiko ^a   Miki, Chikao ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

gastric cancer; lymph node metastasis; prognostic factor; sVAP 1

Indexed keywords

VASCULAR ADHESION PROTEIN 1;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR VOLUME;

ADENOCARCINOMA; AMINE OXIDASE (COPPER-CONTAINING); CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PERITONEUM; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79955472556     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21877     Document Type: Article

References (17)

1. Tominaga S,: Epidemiologic trends of stomach cancer in Japan and world. Nippon Rinsho 2001; 59: 5-12.
2. Ichihara F, Kono K, Takahashi A, et al.: Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003; 9: 4404-4408. (Pubitemid 37248397)
3. Kawaida H, Kono K, Takahashi A, et al.: Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res 2005; 124: 151-157. (Pubitemid 40269816)
4. Butcher EC,: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991; 67: 1033-1036. (Pubitemid 121001517)
5. Springer TA,: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994; 76: 301-314. (Pubitemid 24046692)
6. Salmi M, Jalkanen S,: A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992; 257: 1407-1409.
7. Irjala H, Salmi M, Alanen K, et al.: Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium. J Immunol 2001; 166: 6937-6943. (Pubitemid 32467241)
8. Kurkijärvi R, Adams DH, Leino R, et al.: Circulating form of human vascular adhesion protein-1 (VAP-1): Increased serum levels in inflammatory liver diseases. J Immunol 1998; 161: 1549-1557. (Pubitemid 28380589)
9. Salmi M, Jalkanen S,: Human vascular adhesion protein-1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. J Exp Med 1996; 183: 569-579. (Pubitemid 26060791)
10. Taylor RC, Patel A, Panageas KS, et al.: Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol 2007; 25: 869-875. (Pubitemid 350002888)
11. Galon J, Costes A, Sanchez-Cabo F, et al.: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 29: 1960-1964. (Pubitemid 44498003)
12. Liu JY, Zhang CY, Zhao YN, et al.: Study of anti-breast cancer activity of tumor infiltrating lymphocytes affected by dendritic cells. Ai Zheng 2003; 22: 1030-1033.
13. Lee TB, Min YD, Lim SC, et al.: Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells. J Gastroenterol Hepatol 2002; 17: 32-38.
14. Abella A, Garcia-Vicente S, et al.: Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 2004; 47: 429-438. (Pubitemid 38491239)
15. Kurkijärvi R, Yegutkin GG, Gunson BK, et al.: Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 2000; 119: 1096-1103.
16. Airas L, Mikkola J, Vainio JM, et al.: Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. J Neuroimmunol 2006; 177: 132-135. (Pubitemid 44131575)
17. Toiyama Y, Miki C, Inoue Y,. et al.: Circulating form of human vascular adhesion protein-1 (VAP-1): Decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis. J Surg Oncol 2009; 99: 368-372.